Mariko Miyazawa

No ORCID on file · 2 papers in corpus
other 2021
International journal of molecular sciences ·doi:10.3390/ijms222011220

Ovarian cancers include several disease subtypes and patients often present with advanced metastatic disease and a poor prognosis. New biomarkers for early diagnosis and targeted therapy are, therefore, urgently required. This study uses an…

observational 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0481-9

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy, compared with sero…